December 16, 2013 | Hadasit, the technology transfer company of the Hadassah Medical Center, has signed a $4 million cooperation agreement with Poland’s Synektik SA to develop new imaging agents for non-invasive diagnosis of cardiovascular disease. The imaging agents are for use in PET/ CT scans, enabling physicians to achieve a quantitative measurement of blood flow to the heart.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments